Format

Send to:

Choose Destination
See comment in PubMed Commons below
Metabolism. 2013 Jun;62(6):814-9. doi: 10.1016/j.metabol.2012.12.011. Epub 2013 Feb 11.

Maternal serum retinol-binding protein-4 at 11-13 weeks' gestation in normal and pathological pregnancies.

Author information

  • 1Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK.

Abstract

OBJECTIVE:

To examine maternal serum levels of retinol-binding protein-4 (RBP4) at 11-13 weeks' gestation in normal and pathological pregnancies.

METHODS:

Serum RBP4 at 11-13 weeks was measured in 480 singleton pregnancies, including 240 with normal outcome, 60 that subsequently developed preeclampsia (PE), 60 that developed gestational diabetes mellitus (GDM), 60 that delivered large for gestational age (LGA) neonates and 60 that delivered small (SGA) neonates. The values in each adverse pregnancy outcome group were compared to those of normal pregnancies.

RESULTS:

Serum concentration of RBP4 was not significantly different in women who subsequently developed PE (p=0.925), or GDM (p=0.074), or had pregnancies that led to delivery to SGA (p=0.085), LGA (p=0.332) neonates.

CONCLUSION:

Maternal serum RBP4 in the first trimester is not significantly altered in pathological pregnancies.

Copyright © 2013 Elsevier Inc. All rights reserved.

Comment in

PMID:
23410747
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk